Holen Sie sich die Stockscreener-App
218.90
4.20%
8.82
Handel nachbörslich:
218.90
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$210.08
Offen:
$211.5
24-Stunden-Volumen:
785.96K
Relative Volume:
1.07
Marktkapitalisierung:
$15.73B
Einnahmen:
$2.90B
Nettoeinkommen (Verlust:
$467.20M
KGV:
34.36
EPS:
6.37
Netto-Cashflow:
$306.90M
1W Leistung:
-0.97%
1M Leistung:
+1.43%
6M Leistung:
-37.07%
1J Leistung:
-31.17%
1-Tages-Spanne:
$211.10
$218.90
1-Wochen-Bereich:
$206.80
$226.03
52-Wochen-Spanne:
$187.43
$352.33
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Vergleichen Sie WST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical Names Robert McMahon as New CFO - AInvest
What analysts say about West Pharmaceutical Services Inc. stockUnprecedented profit potential - jammulinksnews.com
WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up? - TradingView
Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks - Insider Monkey
West Pharmaceutical Services Inc. Stock Analysis and ForecastDynamic portfolio growth - jammulinksnews.com
West Pharmaceutical Services taps Robert McMahon as CFO - MSN
Is West Pharmaceutical Services Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional
What drives West Pharmaceutical Services Inc. stock priceHigh-octane investment gains - Autocar Professional
West Pharmaceutical Appoints New CFO Robert McMahon - TipRanks
West pharmaceutical services appoints Robert McMahon as new CFO - Investing.com
Healthcare Veteran Robert McMahon Exits Agilent to Lead West Pharma's Financial Future - Stock Titan
West Welcomes Robert McMahon as Incoming Chief Financial Officer - The Malaysian Reserve
Mutual of America Capital Management LLC Sells 252 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Services Inc (WST) Stock Down 4.76% on July 18th - AInvest
West Pharmaceutical Services to Announce Q2 2025 Results and Host Live Conference Call - MSN
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN
Bank of America Securities Keeps Their Buy Rating on West Pharmaceutical Services (WST) - The Globe and Mail
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory - MSN
Can West Pharmaceutical Services Inc. stock recover from recent declineChart Based Entries - Newser
Allworth Financial LP Has $96,000 Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
How West Pharmaceutical Services Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
West Pharmaceutical Services (WST) to Release Quarterly Earnings on Thursday - Defense World
Strategy To YieldBoost West Pharmaceutical Services From 0.4% To 13.2% Using Options - Nasdaq
Why West Pharmaceutical Services Inc. stock attracts strong analyst attentionFree Stock Index Interpretation - Newser
What makes West Pharmaceutical Services Inc. stock price move sharplyHigh Confidence Trade Setups - Newser
Drug Development Inputs & Services Stocks Q1 Results: Benchmarking West Pharmaceutical Services (NYSE:WST) - Yahoo Finance
Is West Pharmaceutical Services (WST) a Great Business Unfairly Sold Off by the Market? - Insider Monkey
Here's Why West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt Responsibly - simplywall.st
Cambridge Investment Research Advisors Inc. Sells 281 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
Sustainable Pharmaceutical Packaging Market to Reach USD 299.95 billion by 2032 - newstrail.com
Allspring Global Investments Holdings LLC Sells 251 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
WEST ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
West Pharmaceutical Services’ Q2 2025 Earnings: What to Expect - MSN
West to Host Second-Quarter 2025 Conference Call - The Malaysian Reserve
DAVENPORT & Co LLC Has $499,000 Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Sets Q2 Earnings Date: How to Join Live Discussion with Management - Stock Titan
West Pharmaceutical Services, Inc. (WST) LawsuitInvestors Urged to Contact Levi & Korsinsky Before July 7, 2025 - ACCESS Newswire
Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):